NEW YORK (GenomeWeb News) – Natera and LifeLabs Medical Laboratory Services today announced a deal to distribute the Panorama non-invasive prenatal diagnostic test in Canada.
Natera's test was launched in March for the detection of trisomy 21, 18, and 13 and some sex chromosome abnormalities. Last month, detection of triploidy was added to the test.
Financial and other terms of the deal were not disclosed.
"We continue to gain momentum with our global rollout by partnering with leading organizations, such as LifeLabs, and are glad to now expand into Canada," Natera CEO Matthew Rabinowitz said in a statement.
Last week, Illumina said it signed a supply agreement with Natera for Illumina's HiSeq 2500 next-generation sequencing platform and associated Illumina consumables.